Vaccine Hopes Rise as Oxford Jab Prompts Immune Response Among Old as Well as Young Adults

One of the world’s leading COVID-19 experimental vaccines produces an immune response in both young and old adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus. From a report: The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drug maker AstraZeneca Plc, which is…

CNET: Police Are Using Facial Recognition For Minor Crimes, ‘Because They Can’

“Police often frame facial recognition as a necessary tool to solve the most heinous crimes, like terrorist attacks and violent assaults, but researchers have found that the technology is more frequently used for low-level offenses,” reports CNET: In a recent court filing, the New York police department noted that it’s turned to facial recognition in more than 22,000 cases in the…

Massive Criminal Trial Begins For ‘Cyberbunker’ Dark Web Server

The Times of London reports:
A gang of cyberexperts turned a former German military bunker into one of Europe’s biggest hubs for the “dark web” and a superhighway for at least a quarter of a million offences, including drug trafficking and the falsification of identity papers, a court has been told. Four people from the Netherlands, three Germans and a Bulgarian are…

Amazon Launches Program To Pay Consumers For Their Data On Non-Amazon Purchases

An anonymous reader quotes a report from TechCrunch: Amazon has launched a new program that directly pays consumers for information about what they’re purchasing outside of Amazon.com and for responding to short surveys. The program, Amazon Shopper Panel, asks users to send in 10 receipts per month for any purchases made at non-Amazon retailers, including grocery stores, department stores, drug stores…

Remdesivir has ‘no meaningful impact’ on COVID-19 survival, huge study finds

Patients given the drug did not show a significant decrease in mortality, risk of ventilation or time in the hospital. Source: https://www.livescience.com/remdesivir-survival-covid19-coronavirus.html

Remdesivir Has Little Effect on Covid-19 Mortality, WHO Study Says

The Covid-19 treatment remdesivir has no substantial effect on a patient’s chances of survival [Editor’s note: the link may be paywalled; alternative source], a clinical trial by the World Health Organization has found, delivering a significant blow to hopes of identifying existing medicines to treat the disease. From a report: Results from the WHO’s highly anticipated Solidarity trial, which studied the…